Langsung ke konten utama

Christie Introduces far-UVC Light Fixture with Patented Care222 Technology for UV Disinfection

PRESS RELEASE

Christie is pleased to announce the launch of the Christie CounterAct™ line of commercial UV disinfection products with patented Care222® far-UVC light technology for cinemas, theme parks, museums, sports complexes, and other indoor spaces. The Christie fixture uses Ushio’s patented narrowband filtered Care222 excimer lamps that emit far-UVC 222nm light—the only UV technology shown to continuously and significantly reduce pathogens, like coronaviruses, that may also be used while people are present, when used in accordance with specified parameters. Mass production of the new Christie CounterAct fixture starts in January 2021.

Developed by Christie’s parent company, Ushio Inc., and based on technology licensed from Columbia University, the Care222 far-UVC, mercury-free excimer lamp—highlighted in FORTUNE magazine’s annual Change the World list in 2020, includes a proprietary short pass filter that prevents the emission of longer wavelengths of UV light (230nm and higher) that are capable of penetrating human skin and eyes.

Christie CounterAct introduces an added layer of defense against pathogens in indoor venues when guests and staff are present

Christie CounterAct is a line of fixtures that are simple to control remotely and can be installed on ceilings as easily as a commercial lighting fixture. It is suited for use across a wide range of occupied, commercial areas such as entertainment venues—including lobbies, auditoriums, and restrooms—as well as other indoor spaces. The first Christie CounterAct fixture contains two Care222 excimer far-UVC lamps that reduce pathogens on surfaces of any indoor space. The fixture, with fast instant on/off at full output power and its Care222 technology lamps, has been shown effective at reducing pathogens in laboratory tests. Unlike other UV technology, these fixtures with patented Care222 lamps may be used when people are present.

The background on UV light

It has been known for many years that UV light is a highly effective disinfectant that can reduce pathogens in indoor spaces.  Businesses and other institutions have long used germicidal UVC light to stop the spread of viruses. The main drawback with most UVC technology is that it uses a 254nm wavelength that can penetrate human skin and eyes, which means these germicidal lights can only be used when people are not present or while they’re wearing personal protective equipment (PPE) that protects the eyes and skin. These shortcomings constrain how these devices must be operated and limit their widespread use in occupied indoor spaces. 

A study conducted by Kobe University published in August 2020 concludes that, due to its shorter wavelength, far-UVC 222nm light does not penetrate the skin and therefore may be used when humans are present. Another recent study published in the American Journal of Infection Control shows that far-UVC 222nm light can effectively reduce more than 99.7% of surface contamination of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.

Researchers at Columbia University Irving Medical Center have also tested far-UVC 222nm light, and in particular its effect on aerosolized seasonal coronaviruses (that cause the common cold). A scientific paper published by this group in the journal Nature5 in June 2020 found that 99.9% of aerosolized seasonal coronaviruses (the cause of the common cold) were inactivated when exposed to far-UVC 222nm light in just 25 minutes.    

These studies’ findings suggest that the filtered 222nm far-UVC light emitted by Care222 lamps in Christie’s CounterAct fixture, which can operate continuously even when people are present, offers a significant improvement over traditional manual cleaning alone, which requires professional cleaners, and the repeated use of harsh chemicals, in which the results are temporary.

Zoran Veselic, president and COO, Christie, added: “People are essential to the entertainment industry, and their level of comfort in public venues is paramount to the industry’s success.We are very proud to be able to offer this product with Ushio’s Care222 technology to our partners, and we are excited about the possibilities the technology will have in bringing customers back to the places they love, such as movie theaters and theme parks. The fact that far-UVC light—specifically, our new Christie CounterAct far-UVC fixture—can be used in the presence of people is a real differentiating factor. By harnessing these benefits as part of a user-friendly product that can be quickly deployed, we hope to provide a much-needed boost to our partners across the entertainment industry who are currently struggling to attract wary customers.”

For more information visit Christie’s CounterAct website.

The post Christie Introduces far-UVC Light Fixture with Patented Care222 Technology for UV Disinfection appeared first on Boxoffice.



from Boxoffice

Komentar

Posting Komentar

Postingan populer dari blog ini

Kinepolis Group to Open MJR Locations in Michigan, New Theater in Haarlem, Netherlands

Theater chain Kinepolis has opened its new Centrum Schalkwijk location in Haarlem, Netherlands today, October 8—though its inauguration has been postponed to a later date due to the Covid-19 pandemic. In addition, the chain’s 10 MJR Digital Cinemas locations— acquired by Kinepolis in October 2019 , marking the chain’s first foray into the American market—will reopen this weekend. The new cinema is a part of Haarlem’s redeveloped Centrum Schalkwijk shopping center, which contains residential apartments, commercial shops, and an above-ground car park in addition to the new cinema. The theater itself boasts 937 seats across six screens, all  equipped with laser projection. One screen has Laser ULTRA technology, combining 4K laser projection with Dolby Atmos sound.  Kinepolis Haarlem is the Kinepolis Group’s nineteenth cinema in the Netherlands, with the twentieth currently under construction in Leidschendam. Kinepolis has 111 cinemas worldwide total, spread across Europ...
Posting Komentar
Baca selengkapnya

Weekend Box Office Forecast: Focus Features Eyes Back-to-Back #1 Openers with Let Him Go

It’s been — and still is — a wild week for the United States and the entire world as the results of the presidential election remain unknown and the pandemic continues with consistent daily records of new cases. For those seeking some semblance of escapism in a safe and politics-free environment, however, this weekend will provide the latest new release hoping to provide theaters and audiences with fresh content: Let Him Go . The western-drama-thriller starring Diane Lane and Kevin Costner is the latest offering from Focus Features, under Universal Pictures, during exhibition’s mid-pandemic restart. The studio just delivered the top film of last weekend with Come Play , a horror title delivering solid results under the circumstances. Now, Focus is back in action again with what looks to be their second consecutive weekend atop the box office. Let Him Go has earned respectable social media footprints for a film aimed predominately at an audience not known for making significant onlin...
Posting Komentar
Baca selengkapnya

Weekend Forecast: Solstice Studios’ Unhinged and Nolan’s Inception 10th Anniversary Event Set to Welcome Moviegoers Back to Domestic Theaters

To quote Lennon and McCarthy, it’s been a long and winding road. As of this weekend, though, major theater chains across the United States will finally be back up and running with the domestic market’s first wide release since March. Following months of speculation and delayed reopening plans, Solstice Studios’ Unhinged is the film setting the stage for more to come in the weeks and months ahead. It’s a watershed moment oft-planned by the startup distributor throughout the summer as spikes of the COVID-19 pandemic across the country resulted in multiple studio and exhibitor delays, but one that will finally come to pass — and one with significant meaning for exhibitor support. Solstice is releasing the film in 44 states, representing 70 percent of physical theaters. The total theater count is estimated at 2,000, with the expectation of adding between 200 and 300 locations on August 28 when another wave of theaters from major theaters plan to resume operations. Overseas markets have se...
Posting Komentar
Baca selengkapnya